Skip to content

Examination of effects of the classic ketogenic diet on lipid profile and liver function in children with drug-resistant epilepsy

Effects of the classic ketogenic diet on lipid profile and liver function in children with drug-resistant epilepsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240519061838N1
Enrollment
20
Registered
2024-05-30
Start date
2024-06-26
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug resistant epilepsy. Epilepsy and recurrent seizures

Interventions

Intervention group: ketogenic diet with appropriate calories by 4:1 or 3:1 ratio.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 15 Years

Inclusion criteria

Inclusion criteria: Age more than 2 years and less than 15 years The patient's seizures have not been controlled using two first-line anticonvulsants for at least six months, and the patient has an average of one seizure per month. Parents or caregivers should have proper training to start, continue the diet, measure urine ketones, and record information in the relevant form. Informed consent of the patient's parents for the child's participation in the study

Exclusion criteria

Exclusion criteria: The child with liver diseases, progressive neurological disease, metabolic disorders with ammonia levels higher than normal, or other systemic diseases.

Design outcomes

Primary

MeasureTime frame
Liver enzymes level including aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Timepoint: Baseline and 3 months after intervention. Method of measurement: Colorimetric method.

Secondary

MeasureTime frame
Triglyceride level. Timepoint: Baseline and 3 months after intervention. Method of measurement: colorimetric method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhatereh Rezazadeh

Tabriz University of Medical Sciences

rezazadekhatere@gmail.com+98 41 3159 2106

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026